@MYTH©bubu et les 12 comploteurs

MYTH©bubu : Oui il n’y a tellement pas eux d’essais cliniques sur les 5-11ans qu’ils sont publiés dans le NEJM ...

https://www.agoravox.tv/commentaire13360578 :

This phase 1 dose-level identification study and ongoing phase 2–3 safety, immunogenicity, and efficacy trial investigate the administration of the BNT162b2 vaccine to healthy participants 6 months to 11 years of age. Herein we present the results for children 5 to 11 years of age through the cutoff date (September 6, 2021) ; results for children 2 to 4 years and 6 months to less than 2 years of age are not yet available. Participants will be followed for 2 years after receipt of the first dose, including monitoring for potential cases of Covid-19 and MIS-C.

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age / Methods / Participants and Oversight

ClinicalTrials.gov number : NCT04816643.

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults

Estimated Primary Completion Date : May 5, 2026

Estimated Study Completion Date : May 5, 2026

Recruitment Status : Recruiting

«  [C]ontrairement à vous seul la vérité et les faits m’intéresse  !  »

Auteur anonyme, première moitié du XXIe siècle

Heil Μπουρλά !